Journal of Periodontal and Implant Science

  • 제52권2호
  • /
  • Pages.155-169
  • /
  • 2022
  • /
  • 2093-2278(pISSN)
  • /
  • 2093-2286(eISSN)
대한치주과학회 (Korean Academy of Periodontology)
권호 표지
DOI QR코드

DOI QR Code

Insulin growth factor binding protein-3 enhances dental implant osseointegration against methylglyoxal-induced bone deterioration in a rat model

  • Takanche, Jyoti Shrestha (Department of Oral Biochemistry, Institute of Oral Bioscience, School of Dentistry, Jeonbuk National University) ;
  • Kim, Ji-Eun (Department of Oral Biochemistry, Institute of Oral Bioscience, School of Dentistry, Jeonbuk National University) ;
  • Jang, Sungil (Department of Oral Biochemistry, Institute of Oral Bioscience, School of Dentistry, Jeonbuk National University) ;
  • Yi, Ho-Keun (Department of Oral Biochemistry, Institute of Oral Bioscience, School of Dentistry, Jeonbuk National University)
  • 투고 : 2021.02.09
  • 심사 : 2021.07.09
  • 발행 : 2022.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The aim of this study was to determine the effect of insulin growth factor binding protein-3 (IGFBP-3) on the inhibition of glucose oxidative stress and promotion of bone formation near the implant site in a rat model of methylglyoxal (MGO)-induced bone loss. Methods: An in vitro study was performed in MC3T3 E1 cells treated with chitosan gold nanoparticles (Ch-GNPs) conjugated with IGFBP-3 cDNA followed by MGO. An in vivo study was conducted in a rat model induced by MGO administration after the insertion of a dental implant coated with IGFBP-3. Results: MGO treatment downregulated molecules involved in osteogenic differentiation and bone formation in MC3T3 E1 cells and influenced the bone mineral density and bone volume of the femur and alveolar bone. In contrast, IGFBP-3 inhibited oxidative stress and inflammation and enhanced osteogenesis in MGO-treated MC3T3 E1 cells. In addition, IGFBP-3 promoted bone formation by reducing inflammatory proteins in MGO-administered rats. The application of Ch-GNPs conjugated with IGFBP-3 as a coating of titanium implants enhanced osteogenesis and the osseointegration of dental implants. Conclusions: This study demonstrated that IGFBP-3 could be applied as a therapeutic component in dental implants to promote the osseointegration of dental implants in patients with diabetes, which affects MGO levels.

키워드

과제정보

This work was supported by a grant from the National Research Foundation (NRF) of Korea, funded by the Korean government (MSIP) [(NRF-2018R1A2B6004744).

참고문헌

  1. Arroyave F, Montano D, Lizcano F. Diabetes mellitus is a chronic disease that can benefit from therapy with induced pluripotent stem cells. Int J Mol Sci 2020;21:8685. https://doi.org/10.3390/ijms21228685
  2. Kim JB, Jung MH, Cho JY, Park JW, Suh JY, Lee JM. The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitis. J Periodontal Implant Sci 2011;41:109-16. https://doi.org/10.5051/jpis.2011.41.3.109
  3. Jiao H, Xiao E, Graves DT. Diabetes and its effect on bone and fracture healing. Curr Osteoporos Rep 2015;13:327-35. https://doi.org/10.1007/s11914-015-0286-8
  4. Farr JN, Drake MT, Amin S, Melton LJ 3rd, McCready LK, Khosla S. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res 2014;29:787-95. https://doi.org/10.1002/jbmr.2106
  5. Chrcanovic BR, Albrektsson T, Wennerberg A. Diabetes and oral implant failure: a systematic review. J Dent Res 2014;93:859-67. https://doi.org/10.1177/0022034514538820
  6. Daubert DM, Weinstein BF, Bordin S, Leroux BG, Flemming TF. Prevalence and predictive factors for peri-implant disease and implant failure: a cross-sectional analysis. J Periodontol 2015;86:337-47. https://doi.org/10.1902/jop.2014.140438
  7. Michaeli E, Weinberg I, Nahlieli O. Dental implants in the diabetic patient: systemic and rehabilitative considerations. Quintessence Int 2009;40:639-45.
  8. Oates TW, Huynh-Ba G, Vargas A, Alexander P, Feine J. A critical review of diabetes, glycemic control, and dental implant therapy. Clin Oral Implants Res 2013;24:117-27. https://doi.org/10.1111/j.1600-0501.2011.02374.x
  9. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21. https://doi.org/10.1056/NEJM198805193182007
  10. Bourajjaj M, Stehouwer CD, van Hinsbergh VW, Schalkwijk CG. Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem Soc Trans 2003;31:1400-2. https://doi.org/10.1042/bst0311400
  11. Kim KM, Kim YS, Jung DH, Lee J, Kim JS. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp Cell Res 2012;318:152-9. https://doi.org/10.1016/j.yexcr.2011.10.013
  12. Messier C, Gagnon M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav Brain Res 1996;75:1-11. https://doi.org/10.1016/0166-4328(95)00153-0
  13. Gerozissis K. Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 2003;23:1-25. https://doi.org/10.1023/A:1022598900246
  14. Bouillon R. Diabetic bone disease. Calcif Tissue Int 1991;49:155-60. https://doi.org/10.1007/BF02556109
  15. Chan WH, Wu HJ, Shiao NH. Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J Cell Biochem 2007;100:1056-69. https://doi.org/10.1002/jcb.21114
  16. Lee KM, Lee CY, Zhang G, Lyu A, Yue KK. Methylglyoxal activates osteoclasts through JNK pathway leading to osteoporosis. Chem Biol Interact 2019;308:147-54. https://doi.org/10.1016/j.cbi.2019.05.026
  17. Aikawa T, Matsubara H, Ugaji S, Shirakawa J, Nagai R, Munesue S, et al. Contribution of methylglyoxal to delayed healing of bone injury in diabetes. Mol Med Rep 2017;16:403-9. https://doi.org/10.3892/mmr.2017.6589
  18. Jemat A, Ghazali MJ, Razali M, Otsuka Y. Surface modifications and their effects on titanium dental implants. BioMed Res Int 2015;2015:791725. https://doi.org/10.1155/2015/791725
  19. Moraschini V, Poubel LA, Ferreira VF, Barboza ES. Evaluation of survival and success rates of dental implants reported in longitudinal studies with a follow-up period of at least 10 years: a systematic review. Int J Oral Maxillofac Surg 2015;44:377-88. https://doi.org/10.1016/j.ijom.2014.10.023
  20. Chen S, Yang J, Wang H, Chao Y, Zhang C, Shen J, et al. Adenovirus encoding BMP-7 immobilized on titanium surface exhibits local delivery ability and regulates osteoblast differentiation in vitro. Arch Oral Biol 2013;58:1225-31. https://doi.org/10.1016/j.archoralbio.2013.03.019
  21. Wang Y, Huang L. Composite nanoparticles for gene delivery. Adv Genet 2014;88:111-37. https://doi.org/10.1016/B978-0-12-800148-6.00005-5
  22. Bhattarai G, Lee YH, Lee MH, Yi HK. Gene delivery of c-myb increases bone formation surrounding oral implants. J Dent Res 2013;92:840-5. https://doi.org/10.1177/0022034513497753
  23. Bhattarai G, Lee YH, Lee NH, Park IS, Lee MH, Yi HK. PPARγ delivered by Ch-GNPs onto titanium surfaces inhibits implant-induced inflammation and induces bone mineralization of MC-3T3E1 osteoblast-like cells. Clin Oral Implants Res 2013;24:1101-9. https://doi.org/10.1111/j.1600-0501.2012.02517.x
  24. Lee YH, Kim JS, Kim JE, Lee MH, Jeon JG, Park IS, et al. Nanoparticle mediated PPARγ gene delivery on dental implants improves osseointegration via mitochondrial biogenesis in diabetes mellitus rat model. Nanomedicine (Lond) 2017;13:1821-32. https://doi.org/10.1016/j.nano.2017.02.020
  25. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002;84:1032-44. https://doi.org/10.2106/00004623-200206000-00022
  26. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002;23:824-54. https://doi.org/10.1210/er.2001-0033
  27. Bhattarai G, Lee YH, Lee MH, Park IS, Yi HK. Insulin-like growth factor binding protein-3 affects osteogenic efficacy on dental implants in rat mandible. Mater Sci Eng C 2015;55:490-6. https://doi.org/10.1016/j.msec.2015.05.076
  28. Kawai M, Rosen CJ. The insulin-like growth factor system in bone: basic and clinical implications. Endocrinol Metab Clin North Am 2012;41:323-33. https://doi.org/10.1016/j.ecl.2012.04.013
  29. Chard T. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul 1994;4:91-100.
  30. Magnucki G, Schenk U, Ahrens S, Navarrete Santos A, Gernhardt CR, Schaller HG, et al. Expression of the IGF-1, IGFBP-3 and IGF-1 receptors in dental pulp stem cells and impacted third molars. J Oral Sci 2013;55:319-27. https://doi.org/10.2334/josnusd.55.319
  31. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012;19:107-20. https://doi.org/10.1038/cdd.2011.96
  32. Johnson MA, Firth SM. IGFBP-3: a cell fate pivot in cancer and disease. Growth Horm IGF Res 2014;24:164-73. https://doi.org/10.1016/j.ghir.2014.04.007
  33. Kim JE, Takanche JS, Kim JS, Lee MH, Jeon JG, Park IS, et al. Phelligridin D-loaded oral nanotube titanium implant enhances osseointegration and prevents osteolysis in rat mandible. Artif Cells Nanomed Biotechnol 2018;46:397-407. https://doi.org/10.1080/21691401.2018.1458033
  34. Takanche JS, Kim JE, Kim JS, Lee MH, Jeon JG, Park IS, et al. Chitosan-gold nanoparticles mediated gene delivery of c-myb facilitates osseointegration of dental implants in ovariectomized rat. Artif Cells Nanomed Biotechnol 2018;46:S807-17. https://doi.org/10.1080/21691401.2018.1513940
  35. Berlanga J, Cibrian D, Guillen I, Freyre F, Alba JS, Lopez-Saura P, et al. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci (Lond) 2005;109:83-95. https://doi.org/10.1042/CS20050026
  36. Chilelli NC, Burlina S, Lapolla A. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view. Nutr Metab Cardiovasc Dis 2013;23:913-9. https://doi.org/10.1016/j.numecd.2013.04.004
  37. Feng YF, Wang L, Zhang Y, Li X, Ma ZS, Zou JW, et al. Effect of reactive oxygen species overproduction on osteogenesis of porous titanium implant in the present of diabetes mellitus. Biomaterials 2013;34:2234-43. https://doi.org/10.1016/j.biomaterials.2012.12.023
  38. Suh KS, Chon S, Choi EM. Bergenin increases osteogenic differentiation and prevents methylglyoxal-induced cytotoxicity in MC3T3-E1 osteoblasts. Cytotechnology 2018;70:215-24. https://doi.org/10.1007/s10616-017-0135-y
  39. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008;2:1-13. https://doi.org/10.1002/term.63
  40. Young PS, Tsimbouri PM, Gadegaard N, Meek RM, Dalby MJ. Osteoclastogenesis/osteoblastogenesis using human bone marrow-derived cocultures on nanotopographical polymer surfaces. Nanomedicine (Lond) 2015;10:949-57. https://doi.org/10.2217/nnm.14.146
  41. Teitelbaum SL. Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab 2000;18:344-9. https://doi.org/10.1007/s007740070007
  42. Shanmugam N, Kim YS, Lanting L, Natarajan R. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J Biol Chem 2003;278:34834-44. https://doi.org/10.1074/jbc.M302828200
  43. Bansal S, Siddarth M, Chawla D, Banerjee BD, Madhu SV, Tripathi AK. Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro. Mol Cell Biochem 2012;361:289-96. https://doi.org/10.1007/s11010-011-1114-9
  44. Evans DS, Cailotto F, Parimi N, Valdes AM, Castano-Betancourt MC, Liu Y, et al. Genome-wide association and functional studies identify a role for IGFBP3 in hip osteoarthritis. Ann Rheum Dis 2015;74:1861-7. https://doi.org/10.1136/annrheumdis-2013-205020
  45. Deng M, Luo K, Hou T, Luo F, Xie Z, Zhang Z, et al. IGFBP3 deposited in the human umbilical cord mesenchymal stem cell-secreted extracellular matrix promotes bone formation. J Cell Physiol 2018;233:5792-804. https://doi.org/10.1002/jcp.26342